Spillane, D.; Pepe, C.; Kasymjanova, G.; Cruiziat, D.; Cohen, S.; Naimer, J.; Agulnik, J.
Does Pre-Existing Chronic Obstructive Pulmonary Disease Increase the Risk of Checkpoint Inhibitor Pneumonitis in Advanced/Metastatic Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors? Curr. Oncol. 2025, 32, 259.
https://doi.org/10.3390/curroncol32050259
AMA Style
Spillane D, Pepe C, Kasymjanova G, Cruiziat D, Cohen S, Naimer J, Agulnik J.
Does Pre-Existing Chronic Obstructive Pulmonary Disease Increase the Risk of Checkpoint Inhibitor Pneumonitis in Advanced/Metastatic Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors? Current Oncology. 2025; 32(5):259.
https://doi.org/10.3390/curroncol32050259
Chicago/Turabian Style
Spillane, David, Carmela Pepe, Goulnar Kasymjanova, Diane Cruiziat, Sara Cohen, Jeremy Naimer, and Jason Agulnik.
2025. "Does Pre-Existing Chronic Obstructive Pulmonary Disease Increase the Risk of Checkpoint Inhibitor Pneumonitis in Advanced/Metastatic Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors?" Current Oncology 32, no. 5: 259.
https://doi.org/10.3390/curroncol32050259
APA Style
Spillane, D., Pepe, C., Kasymjanova, G., Cruiziat, D., Cohen, S., Naimer, J., & Agulnik, J.
(2025). Does Pre-Existing Chronic Obstructive Pulmonary Disease Increase the Risk of Checkpoint Inhibitor Pneumonitis in Advanced/Metastatic Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors? Current Oncology, 32(5), 259.
https://doi.org/10.3390/curroncol32050259
